Recall D-0650-2024

US Class II Ongoing · initiated 2024-08-22

Recalling firm

ProRx LLC, PA

Product

Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01

Reason for recall

Lack of Assurance of Sterility

← All recalls